共 50 条
- [41] Real-World Clinical and Comparative Effectiveness of Infliximab in Pediatric Crohn's DiseaseGASTROENTEROLOGY, 2013, 144 (05) : S146 - S146Kappelman, MichaelBailey, CharlesCrandall, WallaceZhang, PeixinKing, EileenJoffe, Marshall M.Colletti, Richard B.Forrest, Christopher B.
- [42] Efficacy and safety of ustekinumab in Crohn's disease: A real-world study from AustraliaJOURNAL OF CROHNS & COLITIS, 2020, 14 : S564 - S565Ramaswamy, P. KakkadasamMoattar, H.Sawyer, E.Edwards, J.Shukla, D.
- [43] Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: Results from the UniStar study long-term extensionJOURNAL OF CROHNS & COLITIS, 2023, 17 : 802 - 803Turner, D.Rosh, J. R.Cohen, S. A.Griffiths, A.Hyams, J. S.Kierkus, J.Adedokun, O. J.Strauss, R.Kim, L.Volger, S.
- [44] Real-world study finds similar effectiveness of biologics but higher durability of ustekinumab in patients with Crohn's disease: Preliminary results from the COMPARE-IT Crohn's disease studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 180 - 181Etchegaray, A.Fernandes, R.Anandan, A. ShanmugaSelvanathan, P.Malloy, R.Gilmore, R.Pham, H.Begun, J.An, Y-K
- [45] Does Crohn's disease extent and behavior have an impact on ustekinumab effectiveness? A real-world multicenter retrospective studyJOURNAL OF CROHNS & COLITIS, 2024, 18 : I1488 - I1489Samarentsis, N.Kapizioni, C.Georgakopoulou, N.Michalopoulos, G.Striki, A.Karoumpalis, I.Kartsoli, S.Mellos, A.Vrakas, S.Vougadiotis, I.Neonaki, A.Karatzas, P.Tsiamperas, N.Kourikou, A.Siakavellas, S.Polymeros, D.Manolakopoulos, S.Papatheodoridis, G.Triantafyllou, K.
- [46] Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn′s Disease: A Brazilian Multicentre Real-world StudyAMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S2 - S2Oleg, KnyazevAlbina, LishchinskayaAnatoliy, KonoplyannikovAnna, KagramanovaNina, FadeevaDmitriy, KulakovAnait, BabayanMariya, ZvyaglovaAsfold, Parfenov
- [47] Long-term real-world data of ustekinumab in Crohn's Disease - the Stockholm ustekinumab study - STOCUSTEJOURNAL OF CROHNS & COLITIS, 2022, 16 : I130 - I131Bello, F.Lordal, M.Johansson, F.Sabhan, H.Muhsen, S.Borin, A.Forsberg, O.Wennerstrom, C.Soderman, C.Almer, S.
- [48] The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS ConsortiumAMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (02): : 317 - 328Johnson, Amanda M.Barsky, MariaAhmed, WaseemZullow, SamanthaGalati, JonathanJairath, VipulNarula, NeerajPeerani, FarhadClick, Benjamin H.Coburn, Elliot S.Dang, ThucNhi TranGold, StephanieAgrawal, ManasiGarg, RajatAggarwal, ManikMohammad, DanahHalloran, BrendanKochhar, Gursimran S.Todorowski, HannahUd Din, Nabeeha MohyIzanec, JamesTeeple, AmandaGasink, ChrisMuser, ErikDing, ZhijieSwaminath, ArunLakhani, KomalHogan, DanDatta, SamitUngaro, Ryan C.Boland, Brigid S.Bohm, MatthewFischer, MonikaSagi, SashidharAfzali, AnitaUllman, ThomasLawlor, GarrettBaumgart, Daniel C.Chang, ShannonHudesman, DavidLukin, DanaScherl, Ellen J.Colombel, Jean-FredericSands, Bruce E.Siegel, Corey A.Regueiro, MiguelSandborn, William J.Bruining, DavidKane, SunandaLoftus, Edward V., Jr.
- [49] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinibJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 127 - 128Thin, L.Dubinsky, M.D'Haens, G.Dewit, O.Juillerat, P.Panaccione, R.Fujii, T.Lacerda, A.Dubcenco, E.Anyanwu, S.Doshi, C.Mallick, M.Garrison, A.Liu, J.Loftus, E., Jr.
- [50] CORTICOSTEROID DISCONTINUATION AND CLINICAL OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED WITH UPADACITINIBGASTROENTEROLOGY, 2023, 164 (06) : S1087 - S1088Dubinsky, Marla C.D'Haens, GeertDewit, OlivierJuillerat, PascalPanaccione, RemoFujii, ToshimitsuLacerda, Ana P.Dubcenco, ElenaAnyanwu, SamuelDoshi, ChiragMallick, MadhujaGarrison, AndrewLiu, JianzhongLoftus, Edward V.